Cekaite Lina, Eide Peter W, Lind Guro E, Skotheim Rolf I, Lothe Ragnhild A
Department of Molecular Oncology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
K.G.Jebsen Colorectal Cancer Research Centre, Oslo University Hospital, Oslo, Norway.
Oncotarget. 2016 Feb 9;7(6):6476-505. doi: 10.18632/oncotarget.6390.
Gene expression is in part regulated by microRNAs (miRNAs). This review summarizes the current knowledge of miRNAs in colorectal cancer (CRC); their role as growth regulators, the mechanisms that regulate the miRNAs themselves and the potential of miRNAs as biomarkers. Although thousands of tissue samples and bodily fluids from CRC patients have been investigated for biomarker potential of miRNAs (>160 papers presented in a comprehensive tables), none single miRNA nor miRNA expression signatures are in clinical use for this disease. More than 500 miRNA-target pairs have been identified in CRC and we discuss how these regulatory nodes interconnect and affect signaling pathways in CRC progression.
基因表达部分受微小RNA(miRNA)调控。本综述总结了目前关于miRNA在结直肠癌(CRC)中的知识;它们作为生长调节因子的作用、调节miRNA自身的机制以及miRNA作为生物标志物的潜力。尽管已经对数千份CRC患者的组织样本和体液进行了miRNA生物标志物潜力的研究(综合表格中列出了>160篇论文),但尚无单一miRNA或miRNA表达特征用于该疾病的临床诊断。在CRC中已鉴定出500多个miRNA-靶标对,我们讨论了这些调控节点如何相互连接并影响CRC进展中的信号通路。